| Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cells. | |
| | |
MedLine Citation:
|
PMID: 20662590 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Production of clinical-grade gammaretroviral vectors for ex vivo gene delivery requires a scalable process that can rapidly generate large amounts of vector supernatant, clear large numbers of residual packaging cells with minimal decreases in vector titer, and satisfy all current regulatory guidelines regarding product biosafety. To that end, we have developed a simplified method that is compliant with current good manufacturing practices for the production of clinical-grade gammaretroviral vectors in a clinical research environment. We validated a large-scale production platform utilizing 1,700-cm(2) expanded surface roller bottles and a "modified" step-filtration process consisting of a 40/150-μm dual-screen filter for aggregate removal followed by a Sepacell 500II leukocyte reduction filter for removal of residual packaging cells. This clarification process can clear at least 2 × 10(9) viable producer cells using a single filter set-up without any significant loss of titer post-filtration. This platform typically generates 18 liters of vector supernatant to support small-scale clinical trials, but can easily be scaled up to 70 liters during a single manufacturing run. To date, this platform has generated five clinical-grade gammaretroviral vector products, four of which are now being used in adoptive cell therapy clinical trials for the treatment of a variety of solid cancers. |
| | |
Authors:
|
Steven A Feldman; Stephanie L Goff; Hui Xu; Mary A Black; James N Kochenderfer; Laura A Johnson; James C Yang; Qiong Wang; Maria R Parkhurst; Scott Cross; Richard A Morgan; Kenneth Cornetta; Steven A Rosenberg |
Publication Detail:
|
Type: Journal Article Date: 2010-12-12 |
Journal Detail:
|
Title: Human gene therapy Volume: 22 ISSN: 1557-7422 ISO Abbreviation: Hum. Gene Ther. Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-01-21 Completed Date: 2011-04-28 Revised Date: 2012-01-02 |
Medline Journal Info:
|
Nlm Unique ID: 9008950 Medline TA: Hum Gene Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 107-15 Citation Subset: IM |
Affiliation:
|
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. feldmanst@mail.nih.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cell Culture Techniques / methods* Cell Line Filtration Gammaretrovirus / genetics* Gene Therapy Genetic Vectors* Mice Virus Cultivation / methods |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Nonlinear stimulation and hormesis in human aging: practical examples and action mechanisms.
Next Document: The mammalian zona pellucida: a matrix that mediates both gamete binding and immune recognition?